BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 26159723)

  • 1. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
    Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
    Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
    Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy.
    Uddin S; Ahmed M; Hussain A; Abubaker J; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Jehan Z; Bavi P; Siraj AK; Al-Kuraya KS
    Am J Pathol; 2011 Feb; 178(2):537-47. PubMed ID: 21281787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer.
    Uddin S; Ahmed M; Hussain A; Assad L; Al-Dayel F; Bavi P; Al-Kuraya KS; Munkarah A
    Int J Cancer; 2010 Jan; 126(2):382-94. PubMed ID: 19621391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma.
    Uddin S; Hussain AR; Ahmed M; Siddiqui K; Al-Dayel F; Bavi P; Al-Kuraya KS
    Haematologica; 2012 Jul; 97(7):1092-100. PubMed ID: 22271891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxM1 and its association with matrix metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma.
    Ahmed M; Uddin S; Hussain AR; Alyan A; Jehan Z; Al-Dayel F; Al-Nuaim A; Al-Sobhi S; Amin T; Bavi P; Al-Kuraya KS
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E1-E13. PubMed ID: 22049175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
    Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
    Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
    Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
    Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of FOXM1 by thiostrepton sensitizes medulloblastoma to the effects of chemotherapy.
    Lin J; Zheng Y; Chen K; Huang Z; Wu X; Zhang N
    Oncol Rep; 2013 Oct; 30(4):1739-44. PubMed ID: 23912794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.
    Jiang L; Wang P; Chen L; Chen H
    Int J Clin Exp Pathol; 2014; 7(9):5450-60. PubMed ID: 25337187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer.
    Li W; Cao Y; Xu J; Wang Y; Li W; Wang Q; Hu Z; Hao Y; Hu L; Sun Y; Xu G; Ao G
    J Exp Clin Cancer Res; 2017 Oct; 36(1):144. PubMed ID: 29037225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation.
    Yang K; Jiang L; Hu Y; Yu J; Chen H; Yao Y; Zhu X
    J Exp Clin Cancer Res; 2015 May; 34(1):40. PubMed ID: 25935853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
    Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
    J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.
    Chan-On W; Huyen NT; Songtawee N; Suwanjang W; Prachayasittikul S; Prachayasittikul V
    Drug Des Devel Ther; 2015; 9():2033-47. PubMed ID: 25897210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
    Vishnubalaji R; Hamam R; Yue S; Al-Obeed O; Kassem M; Liu FF; Aldahmash A; Alajez NM
    Oncotarget; 2016 Jun; 7(24):35789-35802. PubMed ID: 27119506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells.
    Zhang X; Cheng L; Minn K; Madan R; Godwin AK; Shridhar V; Chien J
    Oncotarget; 2014 Nov; 5(22):11365-80. PubMed ID: 25426548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer.
    Zhang HG; Xu XW; Shi XP; Han BW; Li ZH; Ren WH; Chen PJ; Lou YF; Li B; Luo XY
    Clin Transl Oncol; 2016 May; 18(5):527-32. PubMed ID: 26370421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel peptide, 9R-P201, strongly inhibits the viability, proliferation and migration of liver cancer HepG2 cells and induces apoptosis by down-regulation of FoxM1 expression.
    Bi Z; Liu W; Ding R; Wu Y; Dou R; Zhang W; Yuan X; Liu X; Xiong L; Guo Z; Mao C
    Eur J Pharmacol; 2017 Feb; 796():175-189. PubMed ID: 28012972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.